X-101359325-G-A

Variant summary

Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong

The NM_000061.3(BTK):​c.862C>T​(p.Arg288Trp) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 23)

Consequence

BTK
NM_000061.3 missense

Scores

15
1
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 4.33
Variant links:
Genes affected
BTK (HGNC:1133): (Bruton tyrosine kinase) The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 17 ACMG points.

PM1
In a domain SH2 (size 96) in uniprot entity BTK_HUMAN there are 13 pathogenic changes around while only 0 benign (100%) in NM_000061.3
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), BTK. . Gene score misZ 4.0394 (greater than the threshold 3.09). GenCC has associacion of gene with short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia, Bruton-type agammaglobulinemia, isolated growth hormone deficiency type III.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.982
PP5
Variant X-101359325-G-A is Pathogenic according to our data. Variant chrX-101359325-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 11366.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-101359325-G-A is described in Lovd as [Pathogenic]. Variant chrX-101359325-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
BTKNM_000061.3 linkuse as main transcriptc.862C>T p.Arg288Trp missense_variant 10/19 ENST00000308731.8 NP_000052.1
BTKNM_001287344.2 linkuse as main transcriptc.964C>T p.Arg322Trp missense_variant 10/19 NP_001274273.1
BTKNM_001287345.2 linkuse as main transcriptc.862C>T p.Arg288Trp missense_variant 11/17 NP_001274274.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
BTKENST00000308731.8 linkuse as main transcriptc.862C>T p.Arg288Trp missense_variant 10/191 NM_000061.3 ENSP00000308176 P3Q06187-1

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Pathogenic, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Pathogenic, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
X-linked agammaglobulinemia Pathogenic:2
Pathogenic, no assertion criteria providedliterature onlyOMIMOct 29, 2018- -
Pathogenic, criteria provided, single submitterclinical testing3billionJan 03, 2022Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000011366, PMID:8162056, PS1_S). The variant has been observed in multiple (>3) similarly affected unrelated individuals(PMID: 15112668, 17765309, 14974089, PS4_S). A different missense change at the same codon has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000492813, PMID:9545398, PM5_M). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.915, PP3_P). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
X-linked agammaglobulinemia;C0472813:X-linked agammaglobulinemia with growth hormone deficiency Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingCenter for Genomics, Ann and Robert H. Lurie Children's Hospital of ChicagoNov 22, 2021BTK NM_000061.2 exon 10 p.Arg288Trp (c.862C>T): This variant has been reported in the literature in at least 3 individuals with X-linked agammaglobulinemia (XLA), segregating with disease in at least 5 affected family members (Mensink 1984 PMID:6595200, deWeers 1994 PMID:8162018, Bradley 1998 PMID:8162056, Kanegane 2001 PMID:11742281, Lopez-Herrera 2008 PMID:17765309). However, individuals from 1 family exhibited significant clinical and immunological heterogenity (Mensink 1984 PMID:6595200, deWeers 1994 PMID:8162018, Bradley 1998 PMID:8162056). This variant is not present in large control databases. This variant is present in ClinVar (Variation ID:11366). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In addition, functional studies also predict that this variant will impact the protein (Tzeng 2000 PMID:11206059, Lopez-Herrera 2008 PMID:17765309). Of note, a different variant at this same codon (p.Arg288Gln) has been reported in the literature in individuals with disease, supporting that this region has significance. In summary, data on this variant is highly suspicious for disease, but requires further evidence for pathogenicity. Therefore, this variant classified as likely pathogenic. -
X-linked agammaglobulinemia with growth hormone deficiency Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpAug 23, 2022This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 288 of the BTK protein (p.Arg288Trp). This missense change has been observed in individuals with X-linked agammaglobulinemia (PMID: 14974089, 15112668, 17765309). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 11366). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BTK protein function. Experimental studies have shown that this missense change affects BTK function (PMID: 11206059). This variant disrupts the p.Arg288 amino acid residue in BTK. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9545398, 12217331, 15661032). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.62
D
BayesDel_noAF
Pathogenic
0.66
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.91
D;.;.;D
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.98
D;D;D;D
M_CAP
Pathogenic
0.91
D
MetaRNN
Pathogenic
0.98
D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.9
.;.;.;H
MutationTaster
Benign
1.0
A;A
PrimateAI
Uncertain
0.77
T
PROVEAN
Pathogenic
-7.0
.;D;.;D
REVEL
Pathogenic
0.92
Sift
Pathogenic
0.0
.;D;.;D
Sift4G
Pathogenic
0.0
D;D;D;D
Polyphen
1.0
.;D;.;D
Vest4
0.89
MutPred
0.85
Loss of disorder (P = 0.0174);Loss of disorder (P = 0.0174);.;Loss of disorder (P = 0.0174);
MVP
1.0
MPC
2.6
ClinPred
1.0
D
GERP RS
5.8
Varity_R
0.97
gMVP
0.99

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs128621194; hg19: chrX-100614313; API